CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
Clinical trial NCT00434031 · WITHDRAWN
Trial details
- NCT number
- NCT00434031
- Sponsor
- National Cancer Institute, Naples
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.